Vivek Ramaswamy is an American entrepreneur and a candidate in the 2024 Republican Party presidential primaries.
Vivek is best known for his company Axovant Sciences, which is known for developing drugs to treat Alzheimer’s.
The company went public in June 2015 at the New York Stock Exchange and was the largest biotech IPO in the United States at that point.
Who is Vivek Ramaswamy?
Vivek Ramaswamy was born Vivek Ganapathy Ramaswamy on August 9, 1985, in Cincinnati, Ohio. His mother, geriatric psychiatrist Geeta Ramaswamy, and his father, General Electric engineer Vivek Ganapathy, immigrated to the U.S. from Vadakkencherry, Palakkad, Kerala, India.
Ramaswamy attended the Jesuit school St. Xavier High School, where he graduated first in his class and excelled at tennis, becoming nationally ranked. He graduated summa cum laude from Harvard College with a Bachelor of Arts degree in biology in 2007, and as a college student, he joined the Phi Beta Kappa fraternity.
Vivek won the Bowdoin Prize for Natural Sciences for his thesis, which was about “the ethical questions raised by creating human-animal chimeras,” and it was published in “The Boston Globe” and “The New York Times.”
In 2011, The Paul & Daisy Soros Fellowships for New Americans awarded Ramaswamy a fellowship to help him work towards a Juris Doctor degree in law at Yale University. He graduated from Yale Law School in 2013.
Career
In 2007, Vivek co-founded the technology company Campus Venture Network with Travis May. The Campus Venture Network provided networking resources and software to college entrepreneurs, and its website was StudentBusinesses.com.
Vivek Ramaswamy and May sold the company to the Ewing Marion Kauffman Foundation in 2009. Vivek worked at QVT Financial from 2007 to 2014, and in addition to being a partner there, he co-managed the company’s biotech portfolio.
In 2014, he founded Roivant Sciences, a pharmaceutical company dedicated to “developing and delivering medicines to patients faster and more efficiently.” Ramaswamy served as the company’s CEO until 2021, and in 2015, he appeared on the cover of “Forbes” magazine due to his work with Roivant.
The “Forbes” story was about Vivek raising more than $350 million for Axovant Sciences, a subsidiary of Roivant, to try to save an Alzheimer’s medication that had failed at fellow pharmaceutical company GlaxoSmith Kline. The drug failed at Axovant in 2017, and in mid-2018, the company’s market value was $276 million.
Presidential Race
Vivek Ramaswamy announced that he was running for president during a February 2023 appearance on “Tucker Carlson Tonight.” According to “Politico,” Vivek wants to “enter the race with an entrepreneurial spirit, unorthodox ideas, and few expectations, and end up developing a major following that will carry him to the presidency.”
Vivek Ramaswamy Net Worth
According to Celebrity Net Worth, Vivek Ramaswamy has an estimated net worth of approximately, $500 million as of August 2023.
Frequently Asked Questions
How old is Vivek Ramaswamy?
Vivek Ramaswamy was born on August 9, 1985, and is currently 36 years old.
How tall is Vivek Ramaswamy?
Vivek Ramaswamy’s height is 1.71 m, which is equal to 5 ft 61 in.
How much is Vivek Ramaswamy Worth?
Vivek Ramaswamy’s net worth is estimated to be $500 Million.
Hopefully, this article was able to provide you with all the necessary information about Vivek Ramaswamy net worth.
THANK YOU for constantly reading stories on AtinkaNews. You are free to share this story via the various social media platforms . Kindly follow us on Facebook, Instagram and Twitter.
